Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Alix Ventures is a venture capital firm based in the United States, specializing in early-stage life science startups. Founded by a team of experienced life science founders, the firm has a portfolio of 14 companies and focuses exclusively on the U.S. market. Their investment strategy emphasizes partnerships with accomplished founders to tackle significant challenges in the life sciences sector.
Alix Ventures invests in the life sciences sector, particularly in early-stage companies within the TechBio landscape. They target startups developing solutions in drug development, tech-enabled diagnostics, genomic data platforms, and clinical trial platforms. Investment sizes typically span pre-seed to seed-plus stages.
Notable companies in Alix Ventures' portfolio include Xilis, which enables precision medicine through patient-derived micro-organoids, and Elegen, focused on full-stack DNA writing. Circularis was acquired by Ginkgo Bioworks, enhancing gene therapy optimization.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.